Inhaled Covid vaccine wins approval

CanSino Biologics (6185) announced that its developed inhaled recombinant Covid-19 XBB1.5 Omicron subvariant vaccine has received approval f...

Related Keywords

China ,Chinese ,Livzon Mabpharm ,Cansino Biologics ,National Medical Products Administration ,National Health Commission ,Sino Biologics ,National Medical Products ,Livzon Pharmaceutical , ,